Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 46 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

19 recruiting

Enrollment Performance

Analytics

N/A

13(39.4%)

Phase 2

11(33.3%)

Phase 4

4(12.1%)

Phase 3

3(9.1%)

Phase 1

2(6.1%)

33Total

N/A(13)

Phase 2(11)

Phase 4(4)

Phase 3(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (46)

Showing 20 of 46 trials

NCT07569055Recruiting

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT06220162Phase 2Recruiting

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Role: collaborator

NCT05376111Phase 2Recruiting

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

Role: collaborator

NCT05657652Not ApplicableRecruiting

CAV Regimen for R/R Ph- B-ALL

Role: collaborator

NCT05657639Phase 2Recruiting

CAV Regimen for R/R AML

Role: collaborator

NCT05901974Phase 2Recruiting

Venetoclax Combined With Azactidine in the Treatment of ALAL

Role: collaborator

NCT05566054Phase 2Recruiting

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Role: collaborator

NCT05940961Phase 2Recruiting

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Role: collaborator

NCT06532552Phase 2Recruiting

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia

Role: collaborator

NCT07141251Phase 1Recruiting

Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

Role: collaborator

NCT06726252Not ApplicableCompleted

Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)

Role: collaborator

NCT05470777Phase 2Recruiting

CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL

Role: collaborator

NCT05149378Phase 2Completed

Venetoclax Based Regimen for R/R T-ALL

Role: collaborator

NCT06916338Recruiting

Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer

Role: collaborator

NCT06916624Recruiting

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

Role: collaborator

NCT06713421Not ApplicableRecruiting

Effect of Premedication With Pronase on Mucosal Cleanliness During EGD

Role: collaborator

NCT06255535Not ApplicableRecruiting

pBFS Guided rTMS Over Cognitive Control Network for ASD

Role: collaborator

NCT06837272Recruiting

A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease

Role: lead

NCT04198207Completed

The Effectiveness and Safety of Vagus Nerve Stimulation for TRE

Role: collaborator

NCT04937803Not ApplicableCompleted

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

Role: collaborator